Tag Archives: Parkinson Disease/drug therapy/metabolism/radionuclide imaging

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD

Guttman M, Stewart D, Hussey D, Wilson A, Houle S, Kish S. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology. June 2001;56(11):1559-1564. Publication Date June 2001 How Analyze was Used “The MRI slices were aligned to the PET data for both studies separately using the ANALYZE software package version 7.5.”…

Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RSJ. Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol. February 1992;31(2):184-192. Publication Date February 1992 How Analyze was Used “Data…